Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis

British Journal of Cancer

Volumn 107, Issue 3, 2012, Pages 422-428

  Weide, B ^a   Elsasser M ^a   Buttner P ^b   Pflugfelder, A ^a   Leiter, U ^a   Eigentler, T K ^a   Bauer, J ^a   Witte, M ^a   Meier, F ^a   Garbe, C ^a,b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b JAMES COOK UNIVERSITY   (Australia)

Author keywords

lactate dehydrogenase; melanoma; metastasectomy; prognosis; S100

Indexed keywords

LACTATE DEHYDROGENASE; PROTEIN S100B;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISTANT METASTASIS; FEMALE; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS RESECTION; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SOFT TISSUE METASTASIS; TREATMENT OUTCOME; VISCERAL METASTASIS;

AGED; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LACTATE DEHYDROGENASES; MALE; MELANOMA; METASTASECTOMY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NERVE GROWTH FACTORS; PROGNOSIS; S100 PROTEINS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84864355514     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.306     Document Type: Article

References (33)

1. Argenyi ZB, Cain C, Bromley C, Nguyen AV, Abraham AA, Kerschmann R, LeBoit PE (1994) S-100 protein-negative malignant melanoma: fact or fiction? A light-microscopic and immunohistochemical study. Am J Dermatopathol 16(3): 233-240
2. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton Jr A, Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF (2001) Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19(16): 3635-3648
3. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S, Eggermont AM, Flaherty KT, Gimotty PA, Kirkwood JM, McMasters KM, Mihm Jr MC, Morton DL, Ross MI, Sober AJ, Sondak VK (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27(36): 6199-6206
4. Deichmann M, Benner A, Bock M, Jackel A, Uhl K, Waldmann V, Naher H (1999) S100-Beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma. J Clin Oncol 17(6): 1891-1896
5. Donato R (2001) S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33(7): 637-668
6. Egberts F, Pollex A, Egberts JH, Kaehler KC, Weichenthal M, Hauschild A (2008) Long-term survival analysis in metastatic melanoma: serum S100B is an independent prognostic marker and superior to LDH. Onkologie 31(7): 380-384
7. Essner R, Lee JH, Wanek LA, Itakura H, Morton DL (2004) Contemporary surgical treatment of advanced-stage melanoma. Arch Surg 139(9): 961-966
8. Eton O, Legha SS, Moon TE, Buzaid AC, Papadopoulos NE, Plager C, Burgess AM, Bedikian AY, Ring S, Dong Q, Glassman AB, Balch CM, Benjamin RS (1998) Prognostic factors for survival of patients treated systemically for disseminated melanoma. J Clin Oncol 16(3): 1103-1111
9. Finck SJ, Giuliano AE, Morton DL (1983) LDH and melanoma. Cancer 51(5): 840-843
10. Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Reinhold U, Kortmann RD, Kettelhack C, Frerich B, Keilholz U, Dummer R, Sebastian G, Tilgen W, Schuler G, Mackensen A, Kaufmann R (2007) Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma. Melanoma Res 17(6): 393-399
11. Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Reinhold U, Kortmann RD, Kettelhack C, Frerich B, Keilholz U, Dummer R, Sebastian G, Tilgen W, Schuler G, Mackensen A, Kaufmann R (2008) Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanoma. Melanoma Res 18(1): 61-67
12. Gerlach R, Demel G, Konig HG, Gross U, Prehn JH, Raabe A, Seifert V, Kogel D (2006) Active secretion of S100B from astrocytes during metabolic stress. Neuroscience 141(4): 1697-1701
13. Hauschild A, Michaelsen J, Brenner W, Rudolph P, Glaser R, Henze E, Christophers E (1999) Prognostic significance of serum S100B detection compared with routine blood parameters in advanced metastatic melanoma patients. Melanoma Res 9(2): 155-161
14. Heimdal K, Hannisdal E, Gundersen S (1989) Regression analyses of prognostic factors in metastatic malignant melanoma. Eur J Cancer Clin Oncol 25(8): 1219-1223
15. Hergovich A, Stegert MR, Schmitz D, Hemmings BA (2006) NDR kinases regulate essential cell processes from yeast to humans. Nat Rev Mol Cell Biol 7(4): 253-264
16. Lasithiotakis KG, Leiter U, Eigentler T, Breuninger H, Metzler G, Meier F, Garbe C (2007) Improvement of overall survival of patients with cutaneous melanoma in Germany, 1976-2001: which factors contributed? Cancer 109(6): 1174-1182
17. Leo F, Cagini L, Rocmans P, Cappello M, Geel AN, Maggi G, Goldstraw P, Pastorino U (2000) Lung metastases from melanoma: when is surgical treatment warranted? Br J Cancer 83(5): 569-572
18. Manola J, Atkins M, Ibrahim J, Kirkwood J (2000) Prognostic factors in metastatic melanoma: a pooled analysis of Eastern Cooperative Oncology Group trials. J Clin Oncol 18(22): 3782-3793
19. Meyer T, Merkel S, Goehl J, Hohenberger W (2000) Surgical therapy for distant metastases of malignant melanoma. Cancer 89(9): 1983-1991
20. Mohammed MQ, Abraha HD, Sherwood RA, MacRae K, Retsas S (2001) Serum S100beta protein as a marker of disease activity in patients with malignant melanoma. Med Oncol 18(2): 109-120
21. Neuman HB, Patel A, Hanlon C, Wolchok JD, Houghton AN, Coit DG (2007) Stage-IV melanoma and pulmonary metastases: factors predictive of survival. Ann Surg Oncol 14(10): 2847-2853
22. Neuman HB, Patel A, Ishill N, Hanlon C, Brady MS, Halpern AC, Houghton A, Coit DG (2008) A single-institution validation of the AJCC staging system for stage IV melanoma. Ann Surg Oncol 15(7): 2034-2041
23. Ollila DW (2006) Complete metastasectomy in patients with stage IV metastatic melanoma. Lancet Oncol 7(11): 919-924
24. Ollila DW, Essner R, Wanek LA, Morton DL (1996) Surgical resection for melanoma metastatic to the gastrointestinal tract. Arch Surg 131(9): 975-979
25. Schmidt H, Sorensen BS, Fode K, Nexo E, von der MH (2005) Tyrosinase messenger RNA in peripheral blood is related to poor survival in patients with metastatic melanoma following interleukin-2-based immunotherapy. Melanoma Res 15(5): 409-416
26. Schroeter ML, Steiner J (2009) Elevated serum levels of the glial marker protein S100B are not specific for schizophrenia or mood disorders. Mol Psychiatry 14(3): 235-237
27. Sirott MN, Bajorin DF, Wong GY, Tao Y, Chapman PB, Templeton MA, Houghton AN (1993) Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis. Cancer 72(10): 3091-3098
28. Smit LH, Korse CM, Hart AA, Bonfrer JM, Haanen JB, Kerst JM, Nieweg OE, de Gast GC (2005) Normal values of serum S-100B predict prolonged survival for stage IV melanoma patients. Eur J Cancer 41(3): 386-392
29. Soong SJ, Ding S, Coit D, Balch CM, Gershenwald JE, Thompson JF, Gimotty P (2010) Predicting survival outcome of localized melanoma: an electronic prediction tool based on the AJCC Melanoma Database. Ann Surg Oncol 17(8): 2006-2014
30. Tarhini AA, Stuckert J, Lee S, Sander C, Kirkwood JM (2009) Prognostic significance of serum S100B protein in high-risk surgically resected melanoma patients participating in Intergroup Trial ECOG 1694. J Clin Oncol 27(1): 38-44
31. Unger JM, Flaherty LE, Liu PY, Albain KS, Sondak VK (2001) Gender and other survival predictors in patients with metastatic melanoma on Southwest Oncology Group trials. Cancer 91(6): 1148-1155
32. Wasif N, Bagaria SP, Ray P, Morton DL (2011) Does metastasectomy improve survival in patients with stage IV melanoma? a cancer registry analysis of outcomes. J Surg Oncol 104(2): 111-115
33. Wood TF, DiFronzo LA, Rose DM, Haigh PI, Stern SL, Wanek L, Essner R, Morton DL (2001) Does complete resection of melanoma metastatic to solid intra-abdominal organs improve survival? Ann Surg Oncol 8(8): 658-662